Algorithm development and the clinical and economic burden of Cushing’s disease in a large US health plan database

被引:0
作者
Tanya Burton
Elisabeth Le Nestour
Maureen Neary
William H. Ludlam
机构
[1] Optum,
[2] InVentiv Health Clinical,undefined
[3] Novartis Pharmaceuticals Corporation,undefined
来源
Pituitary | 2016年 / 19卷
关键词
Cushing’s disease; Case-finding algorithm; Comorbidities; Health care costs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 174
页数:7
相关论文
共 62 条
[1]  
Lacroix A(2015)Cushing’s syndrome Lancet 386 913-927
[2]  
Feelders RA(2013)Medical treatment of Cushing’s disease J Clin Endo Meta 98 425-438
[3]  
Stratakis CA(2008)Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement J Clin Endocrinol Metab 93 2454-2462
[4]  
Nieman LK(2015)Cozzolino A/, Colao A.: the treatment of Cushing’s disease Endocr Rev 36 385-486
[5]  
Feelders RA(2005)A review of uses of health care utilization databases for epidemiologic research on therapeutics J Clin Epidemiol 58 323-337
[6]  
Hofland LJ(2012)The burden of Cushing’s disease: clinical and health-related quality of life aspects Eur J Endocrinol. 167 311-326
[7]  
Biller BMK(2011)Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature J Clin Endocrinol Metab 96 632-642
[8]  
Grossman AB(2011)Health care resource use and costs among patients with Cushing disease Endocr Pract 17 681-690
[9]  
Stewart PM(2015)Incremental healthcare resource utilization and costs in US patients with Cushing’s disease compared with diabetes mellitus and population controls Pituitary 171 88-98
[10]  
Melmed S(2014)Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing’s disease Eur J Endocrinol. undefined undefined-undefined